Equifax Inc.

🇺🇸New York Stock Exchange
Back to all articles
Equifax Inc. stock analysis EFX overview
Slightly Bullish +25

Equifax (EFX) Valuation Check After Recent Share Price Weakness And ...

📉 Equifax shares recently dropped to $178.02, reflecting a 9.84% decline over the past 30 days and a 26.38% drop over the last year.

📊 Despite share price weakness, the company reported annual revenue growth of 8.93% and net income growth of 17.42%.

💰 Intrinsic valuation models suggest Equifax is undervalued with a fair value estimate of $237.60 compared to the current price.

📉 Analysts have lowered their average price target to $237.60, citing higher discount rate assumptions and margin concerns.

⚠️ BofA recently issued a $250 Buy-level target despite recent analyst trimming of price targets.

🏆 Equifax trades at 32.4x earnings, significantly above peers (31.5x) and the US Professional Services industry average (19.1x).

⚖️ Market optimism is evident as the stock trades above its own fair value ratio of 30.9x earnings.

🛡️ Risks include sustained legal costs, tighter state budgets, rising competition, and increasing data privacy scrutiny.

📈 Revenue compounding and firmer margins are key assumptions supporting the higher fair value narrative.

💡 Investors must decide if current valuation premiums represent a margin of safety or require extra conviction.

🔍 Simply Wall St offers analysis on high-quality undervalued stocks and dividend opportunities for portfolio diversification.

⚠️ This article is general commentary based on historical data and analyst forecasts, not financial advice.

🏢 Equifax stock discussed in the analysis includes ticker EFX on the S&P 100 index.

📊 The platform has over 7 million individual investors providing insights on thousands of stocks globally.

⚖️ Sentiment is split between perceived undervaluation and valuation multiples that suggest existing optimism is priced in.

Bullish Signals
  • ,
  • ,
  • ,
Risk Factors
  • Recent share price weakness is evident with a 1.92% decline over 1 day and a significant 9.84% drop over the past 30 days.
  • The 1-year total shareholder return has deteriorated to a 26.38% decline, indicating fading investor momentum.
  • Analysts have trimmed their average price target by approximately $1 to $237.60, reflecting slightly higher discount rate assumptions in valuation models.
  • Equifax trades at a P/E ratio of 32.4x earnings, which exceeds both peers at 31.5x and the broader US Professional Services industry average of 19.1x, suggesting potential overvaluation.
  • Sustained legal costs and rising competition pose ongoing threats to Equifax's positive outlook despite reported revenue growth.
  • Tighter state budgets and increasing data privacy scrutiny could negatively impact future profitability and operational efficiency.
  • A fresh $250 Buy-level target from BofA relies on assumptions of firmer margins and steady compounding that may not materialize given current market pressure.
Full Analysis
Equifax (EFX) has resumed investor attention following recent trading weakness, with shares trading at $178.02 after declining 9.84% over the past 30 days and a 26.38% drop in total shareholder return over the last year. Despite this pullback, fundamentals remain strong, with reported annual revenue growth of 8.93% and net income growth of 17.42%. The current price reflects an indicated intrinsic discount of approximately 54.58%, though analysts have recently trimmed their average price target to $237.60 due to higher discount rate assumptions, modestly stronger revenue growth projections, lower profit margin expectations, and a higher future P/E ratio following a wave of target reductions. Analyst consensus remains mixed regarding the valuation implications of this weakness. While some narratives peg fair value at $237.60 based on steady revenue compounding, firmer margins, and richer earnings multiples, others highlight a significant risk factor in the form of a high price-to-earnings multiple. Equifax currently trades at 32.4x earnings, which is above its peers at 31.5x, the US professional services industry average of 19.1x, and even exceeds a calculated fair P/E ratio of 30.9x. This suggests that while valuation models indicate potential undervaluation, the market may already be pricing in a degree of optimism or that the high multiple requires extra conviction to justify. The article identifies key risks that could challenge the positive outlook, including sustained legal costs, tighter state budgets, rising competition, and data privacy scrutiny. Simply Wall St presents Equifax as an opportunity amidst a broader market of 53 undervalued stocks but warns that sentiment is clearly split between rewards and risks. While BofA has set a $250 Buy-level target, the divergence between intrinsic value models and current market pricing leaves investors to decide whether this represents a margin of safety or a premium needing strong conviction. The analysis concludes that it is an appropriate moment to review data independently, weighing the 4 key rewards against 1 important warning sign to form a balanced view before making investment decisions.